Follow
Meghan (Morrison) Joly
Meghan (Morrison) Joly
PhD, Vanderbilt University Medical Center
Verified email at vumc.org
Title
Cited by
Cited by
Year
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution
JC Stanford, C Young, D Hicks, P Owens, A Williams, DB Vaught, ...
The Journal of clinical investigation 124 (11), 4737-4752, 2014
1322014
Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers
M Morrison Joly, DJ Hicks, B Jones, V Sanchez, MV Estrada, C Young, ...
Cancer research 76 (16), 4752-4764, 2016
1022016
MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
AS Farrell, MM Joly, BL Allen-Petersen, PJ Worth, C Lanciault, D Sauer, ...
Nature communications 8 (1), 1728, 2017
922017
Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells
K Canfield, J Li, OM Wilkins, MM Morrison, M Ung, W Wells, CR Williams, ...
Cell Cycle 14 (4), 648-655, 2015
842015
The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium
JM Balko, TW Miller, MM Morrison, K Hutchinson, C Young, C Rinehart, ...
Proceedings of the National Academy of Sciences 109 (1), 221-226, 2012
822012
Targeting eNOS in pancreatic cancer
BL Lampson, SDS Kendall, BB Ancrile, MM Morrison, MJ Shealy, ...
Cancer research 72 (17), 4472-4482, 2012
752012
Selective mTORC2 inhibitor therapeutically blocks breast cancer cell growth and survival
TA Werfel, S Wang, MA Jackson, TE Kavanaugh, MM Joly, LH Lee, ...
Cancer research 78 (7), 1845-1858, 2018
742018
Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis
M Morrison Joly, MM Williams, DJ Hicks, B Jones, V Sanchez, CD Young, ...
Breast Cancer Research 19, 1-15, 2017
732017
ErbB3 downregulation enhances luminal breast tumor response to antiestrogens
RSC MM Morrison, K Hutchinson, MM Williams, JC
The Journal of Clinical Investigation, 2013
642013
mTOR directs breast morphogenesis through the PKC-alpha-Rac1 signaling axis
MM Morrison, CD Young, S Wang, T Sobolik, VM Sanchez, DJ Hicks, ...
PLoS genetics 11 (7), e1005291, 2015
532015
Using what we already have: uncovering new drug repurposing strategies in existing omics data
JM Pulley, JP Rhoads, RN Jerome, AP Challa, KB Erreger, MM Joly, ...
Annual review of pharmacology and toxicology 60, 333-352, 2020
522020
Key survival factor, Mcl-1, correlates with sensitivity to combined Bcl-2/Bcl-xL blockade
MM Williams, L Lee, DJ Hicks, MM Joly, D Elion, B Rahman, C McKernan, ...
Molecular Cancer Research 15 (3), 259-268, 2017
482017
Activating PIK3CA mutations induce an epidermal growth factor receptor (EGFR)/extracellular signal-regulated kinase (ERK) paracrine signaling axis in basal-like breast cancer
CD Young, LJ Zimmerman, D Hoshino, L Formisano, AB Hanker, ...
Molecular & cellular proteomics 14 (7), 1959-1976, 2015
46*2015
ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation
MM Williams, DB Vaught, MM Joly, DJ Hicks, V Sanchez, P Owens, ...
Breast Cancer Research 19, 1-14, 2017
282017
Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers
MM Williams, L Lee, T Werfel, MMM Joly, DJ Hicks, B Rahman, D Elion, ...
Cell Death & Disease 9 (2), 21, 2018
242018
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth
MM Morrison, MM Williams, DB Vaught, D Hicks, J Lim, C McKernan, ...
Oncogene 35 (9), 1143-1152, 2016
222016
Renin-angiotensin system modulation with synthetic angiotensin (1-7) and angiotensin II type 1 receptor–biased ligand in adults with COVID-19: two randomized clinical trials
WH Self, MS Shotwell, KW Gibbs, M De Wit, DC Files, M Harkins, ...
Jama 329 (14), 1170-1182, 2023
152023
Repurposing of a thromboxane receptor inhibitor based on a novel role in metastasis identified by phenome-wide association study
TA Werfel, DJ Hicks, B Rahman, WE Bendeman, MT Duvernay, JG Maeng, ...
Molecular cancer therapeutics 19 (12), 2454-2464, 2020
142020
Leveraging human genetics to identify safety signals prior to drug marketing approval and clinical use
RN Jerome, MM Joly, N Kennedy, JK Shirey-Rice, DM Roden, ...
Drug safety 43, 567-582, 2020
112020
Evaluating automated electronic case report form data entry from electronic health records
AC Cheng, MK Banasiewicz, JD Johnson, L Sulieman, N Kennedy, ...
Journal of Clinical and Translational Science 7 (1), e29, 2023
92023
The system can't perform the operation now. Try again later.
Articles 1–20